Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A Differentiated Approach to Investing with Growth-Oriented Healthcare Businesses

David Friedman, a Partner with Gauge Capital, a Dallas-based private equity firm with over $2 billion in assets under management, highlights his background, Gauge’s healthcare focus areas for new platform investments in 2022, and their approach to partnering with [growing] businesses. David speaks to the art and science of working within the healthcare sector. It’s…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

David Friedman, a Partner with Gauge Capital, a Dallas-based private equity firm with over $2 billion in assets under management, highlights his background, Gauge’s healthcare focus areas for new platform investments in 2022, and their approach to partnering with [growing] businesses.

David speaks to the art and science of working within the healthcare sector. It’s a complicated space as it is both the largest and fastest-growing sector within the economy. With evolving technology there is a constant opportunity to identify ways to focus on improvements while reducing costs. One thing is likely certain; the healthcare system we know today is going to look very different in the next 10 to 20 years.

In speaking about what makes Gauge Capital different from other investment firms, David clearly conveys what he believes to be the primary differentiator:

“If I was going to point us to one thing that I think makes Gauge different is really our uncompromising focus on alignment.”

Within the private equity space, most firms commit to providing a small portion of the investment from within and the rest of the money comes from outside investors. This allows firms to take minimal risk yet still getting meaningful upside.

At Gauge Capital, the senior investment team represents more than 20% of the Fund Capital in the latest fund. Furthermore, the average management ownership is more than 30% post-close creating strong alignment among Gauge and their partners.

“That just creates the alignment so that all of us are very focused on creating long-term value that drives the business forward,” stated David Friedman.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Health systems are spending big on EHRs and AI while governance gaps widen

Health systems are spending big on EHRs and AI while governance gaps widen

Health systems are investing heavily in electronic health records (EHRs) and artificial intelligence (AI). However, there are notable governance gaps in AI implementation in hospitals. Many hospitals lack dedicated platforms for AI testing and reimbursement issues for AI remain unresolved.

  • 01Health systems are making significant financial investments in electronic health records and AI technology.
  • 02AI reimbursement policies remain unclear, posing challenges for healthcare providers.
  • 03Most hospitals do not have dedicated platforms for testing AI applications.

Aug 17, 2026

Health IT spending, AI gaps, and Epic price tags signal a volatile 2026 for hospital CIOs

Health IT spending, AI gaps, and Epic price tags signal a volatile 2026 for hospital CIOs

The healthcare sector in 2026 is expected to see significant challenges regarding IT spending, especially with electronic health record (EHR) projects that surpass $175 million. There are also gaps in testing artificial intelligence (AI) technologies and an increase in turnover among Chief Information Officers (CIOs), signaling potential volatility within hospital IT departments. These factors are reshaping the pressures on hospital CIOs as they plan for the future.

  • 01EHR projects are exceeding $175 million, causing financial strain on hospital IT budgets.
  • 02There is a notable gap in AI testing and implementation within the healthcare sector.
  • 03Chief Information Officer turnover is rising, contributing to instability in hospital IT leadership.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512